Location: Home
  • search
  • go
  • Relate News
  • 12/16/2014Data Snapshot - Chinese Registration Timeframe for Class 1.1 New Drugs
  • 12/15/2014China's Health Food Reforms Offer More Proposals than Solutions
  • 12/15/2014WuXi PharmaTech to Open Offices in Boston and San Francisco
  • 12/15/2014Data Snapshot - Hospital Drug Consumption and TC Structural Changes in...
  • 12/15/2014Data Snapshot - 2014 Ranking of Chinese Pharma Chemicals Companies
  • 12/15/2014Financial-related Company News in Brief
  • 12/15/2014Luqa Licenses China Rights of Woundcare Drug from Histocell
  • 12/12/2014Suven Gets Another Chinese Patent for Its NECs for Neuro Disorders
  • 12/12/2014GlobalData: Pharma Cos to Lose $65B by 2019 Due To Patent Expiries
  • 12/12/2014Recent Executive Moves
  • 12/12/2014Shanghai Liberalizes Drug Prices Ahead of National Policy Release
  • 12/12/2014CFDA Issues Notice Over Technology Transfer of Sterile Drug Products
  • 12/12/2014China's Evolving Pharma Partnering Landscape: The Right Partner Profil...
  • 12/11/2014Upcoming Event: Asia Vaccine Development Leaders Summit 2015
  • 12/11/2014Fujifim to Sue Sihuan Pharma over IP Infringements Related to Avigan
  • 12/10/2014CFDA VM meets the Czech State Institute for Drug Control Delegation
  • 12/10/2014Cipla Divests from Its Chinese JV in Jiangsu Province
  • 12/10/2014Baker McKenzie: China Ramps Up Antimonopoly Law with Focus on Pharma a...
  • 12/10/2014Deloitte: Returns on Pharma R&D Improving as Pipelines Revive
  • 12/10/2014China's Top Ten Talent Trends for 2015: Will Online Transformation Imp...
  • 12/9/2014NHFPC to Establish National Drug Price Negotiation Committee
  • 12/9/2014Bayer Settles Six-Year Trademark Infringement Lawsuit with Henan Baier...
  • 12/8/2014Thomson Reuters: China's Patent Dominance Despite Stagnant Foreign Inn...
  • 12/8/2014Foreign Drug Companies in China See Approval Delays (External)
  • 12/8/2014Recent Executive Moves
  • 12/5/2014U.S. Dismisses Against Scientists Accused of Selling IP to Hengrui
  • 12/5/2014Wuzhou Pharma Buys Stake of Oramed with $5M Investment
  • 12/5/2014Financial-related Company News in Brief
  • 12/5/2014Waterstone Pharma Licenses Antiviral Drug Candidate from Scynexis
  • 12/5/2014Eisai Opens New Drug Formulation Facility in Suzhou
  • Page:467/790 Total number of articles:23673: [First][<<] [465] [466] [467] [468] [469] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group